Systematic review and meta-analysis of human clinical trials suggests an important role of adiponectin in the development of atherosclerosis, as hypoadiponectinemia was associated with early carotid artery atherosclerosis lesions in healthy and metabolic disease populations (34). Here, ADIPOQ is linked to Other metabolic disease.